Plain-English translation of NCT07379840 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a safety study of finerenone, a medication already approved for treating heart failure, specifically in South Korea. Researchers will collect data from adults with heart failure who are already being prescribed this medication by their doctors as part of their regular medical care. The goal is to make sure the medication is working safely and effectively for South Korean patients.
While this medication has been tested in clinical trials around the world, only a small number of South Korean participants were included in those studies. By gathering more information from South Korean patients taking this treatment, doctors and researchers can better understand how safe and effective it is for this specific population.
You likely qualify if…
You likely don't qualify if…
You would not need to do anything special beyond what you're already doing. Your doctors and their office staff would collect information about your heart failure treatment as part of your regular medical visits and care — just as they normally would. This data would be reported to the research team to help track how well and how safely the medication is working. There are no extra visits, tests, or changes to your usual treatment plan required.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
South Korea